221 related articles for article (PubMed ID: 22957075)
1. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
2. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.
Zhuo W; Zhang L; Wang Y; Ling J; Zhu B; Chen Z
PLoS One; 2012; 7(11):e48265. PubMed ID: 23139769
[TBL] [Abstract][Full Text] [Related]
3. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
Zhou GW; Hu J; Li Q
World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
[TBL] [Abstract][Full Text] [Related]
4. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
5. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
[TBL] [Abstract][Full Text] [Related]
7. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S
BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746
[TBL] [Abstract][Full Text] [Related]
8. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
9. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
[TBL] [Abstract][Full Text] [Related]
10. CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.
Guo Y; Zhou S; Liu F; Zhang B
Int J Clin Exp Pathol; 2015; 8(11):14685-92. PubMed ID: 26823792
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
12. A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.
Cao L; Lin J; He B; Wang H; Rao J; Liu Y; Zhang X
Tumour Biol; 2014 Jan; 35(1):455-62. PubMed ID: 23934444
[TBL] [Abstract][Full Text] [Related]
13. Updated meta-analysis of the association between CYP2E1 RsaI/PstI polymorphisms and lung cancer risk in Chinese population.
Wang YD; Yang HY; Liu J; Wang HY
Asian Pac J Cancer Prev; 2014; 15(13):5411-6. PubMed ID: 25040958
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.
Lin YC; Wu X; Zhou XQ; Ren R; Su ZX; Liu CX
Int J Clin Exp Med; 2015; 8(6):8927-37. PubMed ID: 26309545
[TBL] [Abstract][Full Text] [Related]
16. Analysis of CYP2E1 polymorphism for the determination of genetic susceptibility to gastric cancer in Koreans.
Park GT; Lee OY; Kwon SJ; Lee CG; Yoon BC; Hahm JS; Lee MH; Hoo Lee D; Kee CS; Sun HS
J Gastroenterol Hepatol; 2003 Nov; 18(11):1257-63. PubMed ID: 14535982
[TBL] [Abstract][Full Text] [Related]
17. Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.
Wang FJ; Wang Y; Niu T; Lu WX; Sandford AJ; He JQ
J Clin Pharm Ther; 2016 Jun; 41(3):334-40. PubMed ID: 27062377
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.
Nishimoto IN; Hanaoka T; Sugimura H; Nagura K; Ihara M; Li XJ; Arai T; Hamada GS; Kowalski LP; Tsugane S
Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):675-80. PubMed ID: 10919737
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis on association between genetic polymorphisms of cytochrome P450 2E1 and susceptibility to Chinese gastric cancer].
Mi Y; Liang X; Wu J
Wei Sheng Yan Jiu; 2018 May; 47(3):476-481. PubMed ID: 30082020
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
